<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>14</Volume>
				<Issue>5</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>05</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Video-assisted Thoracoscopic Surgery for Treatment of Earlystage Non-small Cell Lung Cancer</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>2871</FirstPage>
			<LastPage>2877</LastPage>
			<ELocationID EIdType="pii">27710</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;br/&gt;&lt;b&gt;Objectives&lt;/b&gt;: To evaluate the safety, efficacy, and invasiveness of lobectomy by video-assisted thoracoscopicsurgery (VATS) in the treatment of stage I/II non-small cell lung cancer (NSCLC). &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: A total of 148patients presenting with Stage I or II NSCLC were enrolled into our study, comprising 71 who underwent VATSand 77 patients undergoing conventional thoracotomic lobectomy, in combination with systematic lymph noderesection. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: It was found that VATS was superior to conventional thoracotomy in terms of the durationof surgery, intraoperative blood loss, frequency of the need to administer postoperative analgesia, thoracicintubation indwelling time, post-operative hospital stay, and survival rate (P&lt;0.05). We saw no obvious differencein the number of resected lymph nodes with either approach. &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: VATS lobectomy is a safe and reliablesurgical approach for the treatment of Stage I/II NSCLC, characterized by significantly minimal invasiveness,rapid post-operative recovery, and markedly lower loss of blood.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Video-assisted thoracscopic surgery</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Lung cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">lobectomy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">lymph node dissection</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Prognosis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_27710_b005a277ca68b405b7f5fb8ac1843554.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
